Morgan Stanley raised the firm’s price target on Fresenius SE (FSNUY) to EUR 41 from EUR 40 and keeps an Overweight rating on the shares.

Germany equities were lower at the close on Friday, as losses in the DAX Construction, DAX Technology and DAX Retail sectors ...

Germany stocks were lower after the close on Friday, as losses in the Construction, Technology and Retail sectors led shares ...

DaVita’s strong services face risks from debt and economic uncertainties. Find out why DVA stock is a "Hold" with a $130 ...

Third Quarter 2024 Results Key Financial Results Revenue: €5.37b (up 3.5% from 3Q ...

Deutsche Bank raised the firm’s price target on Fresenius SE (FSNUY) to EUR 44 from EUR 42 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate source for real-time, ...

Fresenius SE operates with an investment-grade credit profile, and Fresenius SE recently deconsolidated its position in Fresenius Medical Care, along with its debt. As of September 2024, Fresenius ...

Fresenius reported third-quarter revenue of 5.30 billion euros ($5.69 billion) and EBIT before special items of 522 million euros, beating a company-provided consensus by 1.7% and 3.4% respectively.

The healthcare company lifted its full-year guidance after a robust third quarter driven by Kabi and good organic growth at ...

Germany's Fresenius raised its full-year outlook on Wednesday after beating third-quarter expectations, citing strong ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...